0 Bewertungen

ID

33572

Beschreibung

Study ID: 106904 Clinical Study ID: CRV106904 Study Title: A Randomized, Open-Label, Single-Dose, Four-Period Cross-Over Study to Determine the Effects of Alcohol on the Pharmacokinetics of Carvedilol CR Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier:  Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: carvedilol Trade Name: Coreg CR,Coreg Study Indication: Hypertension

Stichworte

  1. 08.11.18 08.11.18 -
  2. 13.12.18 13.12.18 -
Rechteinhaber

GSK group of companies

Hochgeladen am

13. Dezember 2018

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY-NC 3.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :


    Keine Kommentare

    Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

    A Cross-Over Study of Alcohol Effect on the Pharmacokinetics of Carvedilol - 106904

    Eligibility Question

    1. StudyEvent: ODM
      1. Eligibility Question
    Administrative data
    Beschreibung

    Administrative data

    Alias
    UMLS CUI-1
    C1320722
    Site
    Beschreibung

    Site

    Datentyp

    text

    Alias
    UMLS CUI [1]
    C2825164
    Patient
    Beschreibung

    Patient

    Datentyp

    text

    Alias
    UMLS CUI [1]
    C1299487
    Patient Number
    Beschreibung

    Patient Number

    Datentyp

    integer

    Alias
    UMLS CUI [1,1]
    C0030705
    UMLS CUI [1,2]
    C1300638
    Eligibility Question
    Beschreibung

    Eligibility Question

    Alias
    UMLS CUI-1
    C1516637
    Did the subject meet all the entry criteria?
    Beschreibung

    Did the subject meet all the entry criteria?

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C1516637
    Do not admit he subject into this study if any Inclusion/Exclusion criteria is violated unless an exception has been granted by the GSK Medical Monitor and subject is continuing in the study. Please clarify the exemption(s) below
    Beschreibung

    Do not admit he subject into this study if any Inclusion/Exclusion criteria is violated unless an exception has been granted by the GSK Medical Monitor and subject is continuing in the study. Please clarify the exemption(s) below

    Datentyp

    text

    Alias
    UMLS CUI [1]
    C0030673
    UMLS CUI [2,1]
    C1512693
    UMLS CUI [2,2]
    C1709750
    UMLS CUI [3]
    C0680251

    Ähnliche Modelle

    Eligibility Question

    1. StudyEvent: ODM
      1. Eligibility Question
    Name
    Typ
    Description | Question | Decode (Coded Value)
    Datentyp
    Alias
    Item Group
    Administrative data
    C1320722 (UMLS CUI-1)
    Site
    Item
    Site
    text
    C2825164 (UMLS CUI [1])
    Patient
    Item
    Patient
    text
    C1299487 (UMLS CUI [1])
    Patient Number
    Item
    Patient Number
    integer
    C0030705 (UMLS CUI [1,1])
    C1300638 (UMLS CUI [1,2])
    Item Group
    Eligibility Question
    C1516637 (UMLS CUI-1)
    Did the subject meet all the entry criteria?
    Item
    Did the subject meet all the entry criteria?
    boolean
    C1516637 (UMLS CUI [1])
    Do not admit he subject into this study if any Inclusion/Exclusion criteria is violated unless an exception has been granted by the GSK Medical Monitor and subject is continuing in the study. Please clarify the exemption(s) below
    Item
    Do not admit he subject into this study if any Inclusion/Exclusion criteria is violated unless an exception has been granted by the GSK Medical Monitor and subject is continuing in the study. Please clarify the exemption(s) below
    text
    C0030673 (UMLS CUI [1])
    C1512693 (UMLS CUI [2,1])
    C1709750 (UMLS CUI [2,2])
    C0680251 (UMLS CUI [3])

    Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

    Zum Video